europsychological evaluation and rehabilitation in multiple sclerosis – feasibility study

Not Applicable

Completed

• Conditions: Multiple sclerosis; Nervous System Diseases

• Registration Number: ISRCTN11203922
• Lead Sponsor: ottinghamshire Healthcare NHS Foundation Trust

Brief Summary

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35690797/ (added 13/06/2022)

Detailed Description

Not available

Study Timeline

• Study Start: 2021-02-09
• Study Completion: 2023-09-30
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 2354

Inclusion Criteria

Current inclusion criteria as of 21/07/2022:

All individuals:
Able and willing to give consent and able to communicate in English. Participant information sheets can be provided in Welsh upon request but the standardised materials and tests to be used require communication in English since these have not yet been developed for other languages.

Part 1 – testing the cognitive screening pathway:
People with MS:
1. Diagnosis of MS
2. Aged 18 years or above

Part 2 – acceptability, feasibility RCT and fidelity evaluation:
People with MS:
1. Diagnosis of MS
2. Received cognitive screening and mild or moderate cognitive problems identified (Part 1)
3. Aged 18 years or above

Part 3 – interviews:
1. People with MS:
1.1. People with MS participated in Part 2
2. Intervention providers:
2.1. Assistant Psychologist/Research Nurses/Assistant Occupational Therapist delivering the NEuRoMS intervention to people with MS in Part 2
3. Clinicians:
3.1. Health professionals (e.g., neurologists, MS nurse specialists, psychologists, occupational therapists) delivering the NEuRoMS screening and management pathway to people with MS
_____

Previous inclusion criteria:

All individuals:
Able and willing to give consent and able to communicate in English. Participant information sheets can be provided in Welsh upon request but the standardised materials and tests to be used require communication in English since these have not yet been developed for other languages.

Part 1 – testing the cognitive screening pathway:
People with MS:
1. Diagnosis of MS
2. Aged 18 years or above

Part 2 – acceptability, feasibility RCT and fidelity evaluation:
People with MS:
1. Diagnosis of MS
2. Received cognitive screening and mild cognitive problems identified (Part 1)
3. Aged 18 years or above

Part 3 – interviews:
1. People with MS:
1.1. People with MS participated in Part 2
2. Intervention providers:
2.1. Assistant Psychologist/Research Nurses/Assistant Occupational Therapist delivering the NEuRoMS intervention to people with MS in Part 2
3. Clinicians:
3.1. Health professionals (e.g., neurologists, MS nurse specialists, psychologists, occupational therapists) delivering the NEuRoMS screening and management pathway to people with MS

Exclusion Criteria

Part 2 participants only:
1. Currently receiving neuropsychological intervention for cognitive problems
2. Received NEuRoMS intervention during WP2ii

All participants:
1. Does not have the mental capacity to consent to take part in the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified